openPR Logo
Press release

Comprehensive 2025 Glycopeptide Antibiotics Market Overview: Trends, Forecasts, and Growth Drivers

07-03-2025 08:23 AM CET | Health & Medicine

Press release from: The Business Research Company

Glycopeptide Antibiotics Market

Glycopeptide Antibiotics Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Glycopeptide Antibiotics Market Through 2025?
The market size of glycopeptide antibiotics has witnessed significant growth in the past few years. This market is projected to expand from $3.54 billion in 2024 to $3.82 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.0%. The previously observed growth can be linked to factors such as escalating antibiotic resistance, a growing number of infectious disease cases, initiatives by the government, increases in healthcare spending, and the global spread of infectious diseases.

What's the Projected Size of the Global Glycopeptide Antibiotics Market by 2029?
In the coming years, the market size of glycopeptide antibiotics is projected to witness solid growth, reaching $5.5 billion in 2029 with a compound annual growth rate (CAGR) of 9.5%. The surge in the projected period is due to various factors like the rise in infectious diseases, growing elderly population, constant challenges with antibiotic resistance, investments and advancements in research and development, and the expansion of the healthcare infrastructure. The major market trends during the predicted period encompass increasing antibiotic resistance, innovations in research and development, demand driven by global health crises, partnerships for antibiotic stewardship, and market growth in developing economies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report

Top Growth Drivers in the Glycopeptide Antibiotics Industry: What's Accelerating the Market?
The increasing cases of cancer and infectious diseases are projected to fuel the advancement of the glycopeptide antibiotics market. Cancer is a condition in which certain cells in the body grow uncontrollably and spread to other parts of the body. Infectious diseases, on the other hand, are illnesses triggered by organisms like bacteria, viruses, fungi, or parasites. Glycopeptide antibiotics are employed to cure various infectious ailments caused by methicillin-resistant staphylococcus aureus, streptococcus, or enterococcus bacteria that show resistance to beta-lactams and other antibiotics. For cancer patients, these antibiotics are used to augment the antitumor impact of radiotherapy by eliminating not just the targeted cancer cells, but also the distant ones in the body. For example, as per the American Cancer Society, a non-profit health institution aiming for cancer elimination based in the US, the nation had 1.9 million fresh cases of cancer and 609,360 mortalities due to it, amounting to 1,670 deaths every day, in 2022. Consequently, the escalating incidences of cancer and infectious diseases are forecasted to spur the glycopeptide antibiotics market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9444&type=smp

What Trends Will Shape the Glycopeptide Antibiotics Market Through 2029 and Beyond?
Product innovation is emerging as a significant trend in the glycopeptide antibiotics market. Major firms in the market are concentrating on the development of innovative products to solidify their market presence. In October 2022, for example, Leiden University, rooted in the Netherlands, uncovered new variations of the antibiotic vancomycin. They did this by attaching a group of molecules to an existing vancomycin molecule, thereby crafting a new variant of the antibiotic. This new version of vancomycin proves to be up to a thousand times more potent against gram-positive bacteria in comparison to the original vancomycin and exhibits lesser nephrotoxicity compared to typically utilized polymyxin antibiotics. The need to create this arose due to vancomycin's limitation of only being effective against gram-positive strains and its inability to penetrate the outer membrane (OM) of gram-negative bacteria.

What Are the Main Segments in the Glycopeptide Antibiotics Market?
The glycopeptide antibiotics market covered in this report is segmented -

1) By Drug: Vancomycin, Dalbavancin, Oritavancin, Other Drugs
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By Indication: Skin And Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Other Indications
4) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsemgents:
1) By Vancomycin: Vancomycin Injection, Vancomycin Oral Solution, Vancomycin Capsules, Vancomycin Powder for Solution
2) By Dalbavancin: Dalbavancin IV (Intravenous) Formulation, Dalbavancin Powder for Injection
3) By Oritavancin: Oritavancin IV (Intravenous) Formulation,Oritavancin Powder for Injection
4) By Other Drugs: Teicoplanin, Linezolid, Daptomycin, Other Glycopeptide and Lipoglycopeptide Antibiotics

4o

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9444&type=smp

Which Top Companies are Driving Growth in the Glycopeptide Antibiotics Market?
Major companies operating in the glycopeptide antibiotics market include ANI Pharmaceuticals Inc., Fresenius SE & Co. KGaA, Pfizer Inc., Novartis AG, Hikma Pharmaceuticals Plc., Aurobindo Pharma Limited, Abbvie Inc., Cumberland Pharmaceuticals Inc., Janssen Global, Bristol-Myers Squibb Company, Shenwei Pharmaceutical Hainan Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd., Alvogen, Bayer AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi SA, GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim GmbH, Cipla Inc.

Which Regions Will Dominate the Glycopeptide Antibiotics Market Through 2029?
North America was the largest region in the glycopeptide antibiotics market in 2024. The regions covered in the glycopeptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9444

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Comprehensive 2025 Glycopeptide Antibiotics Market Overview: Trends, Forecasts, and Growth Drivers here

News-ID: 4090619 • Views:

More Releases from The Business Research Company

Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up to 2030
Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up …
The signal conditioning modules market is on track for significant expansion over the coming years, driven by advancements in various industrial and technological sectors. This growth reflects the increasing need for precise signal management and integration with emerging smart technologies that are shaping modern automation and data acquisition systems. Projected Growth Trajectory of the Signal Conditioning Modules Market The signal conditioning modules market is anticipated to reach a valuation of $1.77
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
The set-top box market is on the cusp of significant expansion as technology and consumer preferences continue to evolve rapidly. With the increasing demand for advanced streaming and broadcasting solutions, this sector is poised for substantial growth over the coming years. Let's explore the market's projected size, leading companies, key trends, and the segments driving this development. Projected Market Growth of the Set-Top Box Industry by 2030 The set-top box market
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Wafer Market
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Waf …
The semiconductor wafer sector is gearing up for significant expansion as technological advancements and diverse industry demands drive its growth. With applications spanning from electric vehicles to telecommunications, this market is positioned for steady development in the years ahead. Let's explore the anticipated market size, key players, emerging trends, and segmentation details shaping the future of this vital industry. Projected Market Size and Growth Trajectory of the Semiconductor Wafer Market Forecasts
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Equipment Market
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Eq …
The semiconductor manufacturing equipment market is poised for significant expansion as the demand for high-performance chips and advanced packaging technologies continues to grow. This evolving sector is driven by technological progress and increased investments, setting the stage for substantial developments through 2030. Projected Semiconductor Manufacturing Equipment Market Size and Growth The semiconductor manufacturing equipment market is forecasted to reach a value of $196.07 billion by 2030, growing at a compound annual

All 5 Releases


More Releases for Glycopeptide

Emerging Trends to Reshape the Glycopeptide Antibiotics Market: Leiden Universit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Glycopeptide Antibiotics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for glycopeptide antibiotics has seen substantial growth in the last few years. The figures are expected to rise from $3.54 billion in 2024 to $3.78 billion in 2025, reflecting a compound annual
The Surging Demand For Glycopeptide Antibiotics In The Face Of Rising Cancer And …
The Glycopeptide Antibiotics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Glycopeptide Antibiotics Market Size and Projected Growth Rate? The market size for glycopeptide antibiotics has witnessed significant expansion in the past few years. Anticipated to rise from $3.54 billion in 2024 to
Glycopeptide Antibiotics Market 2024: Trends and Growth Opportunities
The Business Research Company recently released a comprehensive report on the Global General Medical And Surgical Hospitals Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The general
Glycopeptide Antibiotics Market: Analysis, Trends & Forecast 2024-2033 | Growth, …
The glycopeptide antibiotics market size has grown strongly in recent years. It will grow from $3.31 billion in 2023 to $3.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing antibiotic resistance, rising incidence of infectious diseases, government initiatives, increasing healthcare expenditure, globalization of infectious diseases. The glycopeptide antibiotics market size is expected to see
Antibiotic Advancements: Glycopeptide Antibiotics Market Surges with Trends, Gro …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Glycopeptide Antibiotics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The glycopeptide antibiotics market size has grown strongly in recent years. It
Glycopeptide Antibiotics Market is Expected Significant Growth, From 2022 to 203 …
Global Glycopeptide Antibiotics Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis Glycopeptide Antibiotics Market Overview The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Glycopeptide Antibiotics Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the